了解和治疗周围动脉疾病的实用指南
Maya R Chilbert1, Ashley E Woodruff1, Kelly C Rogers2
1Department of Pharmacy, University at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Buffalo General Medical Center; and.
Journal of cardiovascular pharmacology
|March 7, 2024
概括
周围动脉疾病 (PAD) 诊断不足,治疗不足. 早期查和风险因素管理,包括血压和脂质控制,对于更好的患者结果至关重要.
科学领域:
- 心血管医学 心血管医学
- 血管外科 血管外科
背景情况:
- 周围动脉疾病 (PAD) 是动脉样硬化发病的一个重要原因,与冠状动脉疾病和中风相比,经常被忽视.
- PAD的诊断不足和治疗不足限制了患者获得基本治疗和风险因素修改的机会.
- PAD的主要风险因素包括糖尿病和吸烟,需要有针对性的干预措施.
研究的目的:
- 提供周围动脉疾病 (PAD) 的全面概述.
- 总结目前的临床试验证据和PAD查和治疗的指导方针建议.
- 提高医疗保健提供者对PAD的认识,以改善患者护理.
主要方法:
- 这篇叙事综述综合了关于PAD查和治疗的现有文献.
- 总结了指导方针建议和临床试验数据.
- 专注于风险因素管理和个性化治疗策略.
主要成果:
- 对糖尿病和吸烟等危险因素的有效管理可以改善PAD的结果.
- 血压和脂质控制对于减轻PAD症状和表现至关重要.
- 根据患者特定的因素,建议个性化使用抗血栓药物.
结论:
- 医疗保健提供者应将PAD查纳入风险人群的常规护理.
- 早期诊断和指导方针导向的治疗启动对于减少不良心血管和肢体事件至关重要.
- 提高提供者意识和遵守治疗指南可以积极影响患者的护理和结果.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
157
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
157
Pulse Assessment Sites
1.0K
Pulse assessment sites are crucial in evaluating a patient's cardiovascular health. By assessing the pulsations of arteries at specific anatomical locations, healthcare professionals can gather valuable information about blood flow, heart rate, and peripheral circulation. Understanding these pulse assessment sites is essential for conducting comprehensive cardiovascular evaluations and monitoring patients' overall health. These sites are strategically chosen due to the accessibility and...
1.0K
Assessment of the Cardiovascular System III: Palpation
337
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
337
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
166
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
166
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
Pre-Procedural Guidelines for Assessing Blood Pressure
563
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
563


